Company news
Polaris Group (TWSE:6550) news
Polaris Group news releases on 6ix. Latest, Sep 28, 2026: Lombard backs Polaris Autoliners fleet expansion with 33.2 million refinancing deal
Press releases & updates
Lombard backs Polaris Autoliners fleet expansion with 33.2 million refinancing deal
September 28, 2026
Polaris Group Announced the Acquisition of Genovior Biotech, Initiating Dual-Engine Growth
December 20, 2023
Polaris Group Initiates Phase 3 Trial: First Patient Successfully Dosed with ADI-PEG 20/Placebo plus Gemcitabine and Docetaxel for Difficult-to-Treat Leiomyosarcoma (LMS)
December 4, 2023
Polaris Group Announces First Patient Successfully Dosed with ADI-PEG 20/Placebo in Phase 2a Non-Alcoholic Steatohepatitis (NASH) Study
November 28, 2023
Polaris Group Initiates Rolling Submission of Biologic License Application (BLA) for ADI-PEG 20 with U.S. FDA to Treat Malignant Pleural Mesothelioma
November 15, 2023
Polaris : The Board resolved the consolidated financial statements for the second quarter of 2022
August 16, 2022
Polaris : Board of Directors resolved to issue employee stock options certificates
August 16, 2022
Polaris : Announcement for appointing the Corporate Governance Officer
August 16, 2022
Polaris : (Announcement of correction) Polaris Group will attend 2022 Cathay Biopharmaceutical Corporate DayHosted by Cathay Securities.
August 15, 2022
Polaris : Announcement of the progress of the company's committed items at the time when the stock was listed on TWSE.
July 8, 2022